 |
|
Chlorpromazine JaundiceClinical Course, Hepatic-Function Tests, and Pathologic Findings—Summary of Twenty Cases
WILLIAM F. GEBHART, M.D.;
RAY A. VAN OMMEN, M.D.;
LAWRENCE J. McCORMACK, M.D.;
CHARLES H. BROWN, M.D.
AMA Arch Intern Med. 1958;101(6):1085-1093.
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings. |
|
|
|
Jaundice due to chlorpromazine (Thorazine) hydrochloride has been reported in more than 120 cases in the medical literature. Since our original report of 3 cases,1 we have seen 17 additional patients with this complication. Several of these patients had prolonged jaundice, and two incurred jaundice during pregnancy.
The clinical and laboratory manifestations of this disease are now well known. It is the purpose of this paper to describe our clinical experience with a comparatively large number of patients having chlorpromazine jaundice and to report in detail findings on liver biopsies that were performed in 15 of our 20 patients.
Incidence and Mechanism
The incidence of jaundice in patients treated with chlorpromazine has been reported to be as low as 0.2%2,3 and as high as 5%,4,5 although generally it is considered to approach more nearly 1 %.6 The liver disease so produced usually is regarded as a benign
. . . [Full Text PDF of this Article]
Author Affiliations
Cleveland
From the Departments of Gastroenterology (Dr. Gebhart, Former Fellow; Dr. Brown, Member of Staff), Internal Medicine (Dr. Van Ommen), and Pathology (Dr. McCormack) of the Cleveland Clinic Foundation and The Frank E. Bunts Educational Institute.
Footnotes
Submitted for publication Oct. 11, 1957.
This paper is based on a thesis that was submitted by Dr. Gebhart in partial fulfillment of his fellowship requirements at the Cleveland Clinic.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
|
